# FDA recall D-1396-2012

> **Teva Pharmaceuticals USA, Inc.** · Class II · drug recall initiated 2012-04-02.

## Product

Mefloquine HCL Tablets, 250 mg, 5 tablets per blister pack; 5 Blister packs per carton, Rx only, Teva Pharmaceuticals USA Sellersville, PA 18960, Individual blister pack: NDC 0555-0171-88, 25 Unit-Dose Tablets (5x5) Carton: NDC 0555-0171-78

## Reason for recall

Tablet Thickness: Product is being recalled due to the potential of being underweight or overweight.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1396-2012
- **Recalling firm:** Teva Pharmaceuticals USA, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-04-02
- **Report date:** 2012-07-04
- **Termination date:** 2013-03-22

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Sellersville, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1396-2012

## Citation

> AI Analytics. FDA recall D-1396-2012. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1396-2012. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*